Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock is traded on the NASDAQ Global Select Market under the trading symbol MPAA. As of June 2, 2025, there were 19,435,706 shares of common stock outstanding held by 8 holders of record.
Purchases of Equity Securities by the Issuer
Share repurchase activity during the fourth quarter of fiscal 2025 was as follows:
Periods
Total Number of
Shares Purchased
Average Price
Paid Per Share
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
Approximate
Dollar Value of
Shares That May
Yet Be Purchased
Under the
Plans
or Programs (1)
January 1 - January 31, 2025:
Open market and privately negotiated purchases
-
$ -
-
$ 16,159,000
February 1 - February 28, 2025:
Open market and privately negotiated purchases
58,068
$ 9.42
547,000
15,612,000
March 1 - March 31, 2025:
Open market and privately negotiated purchases
215,936
$ 10.14
2,189,000
13,423,000
Total
274,004
2,736,000
$ 13,423,000
(1)
As of March 31, 2025, $23,577,000 of the $37,000,000 authorized under our share repurchase program was utilized and $13,423,000 remains available to repurchase shares under this program, subject to the limit in our credit facility and convertible notes. We retired the 1,379,141 shares repurchased under this program through March 31, 2025. Our share repurchase program does not obligate us to acquire any specific number of shares and shares may be repurchased in privately negotiated and/or open market transactions.
During the quarter ended March 31, 2025, we adopted a written trading plan under Rule 10b5-1 of the SEC rule to facilitate share repurchases under our current authorized program. The adoption of a 10b5-1 plan allows us the ability to repurchase shares when we would be ordinarily restricted from purchases due to blackout periods or being in possession of material non-public information.
Equity Compensation Plan Information
The following summarizes our equity compensation plans as of March 31, 2025:
Plan Category
Number of securities to
be issued upon
exercise of outstanding
options, warrants and
rights
(a)
Weighted-average
exercise price of
outstanding options
warrants and rights
(b)
Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))
(c)
Equity compensation plans approved by security holders
2,323,321
(1)
$ 9.32
(2)
1,516,084 (3)
Equity compensation plans not approved by security holders
N/A
N/A
N/A
Total
2,323,321
$ 9.32
1,516,084
(1) Consists of (i) 52,842 restricted stock units (“RSUs”), 119,708 performance
stock units (“PSUs”), and 922,628 stock options issued under the Fourth Amended
and Restated 2010 Incentive Award Plan (the “2010 Plan”) and (ii) 452,531 RSUs,
644,679 PSUs, and 130,933 stock options issued under our First Amended and
Restated 2022 Incentive Award Plan (the “2022 Plan”).
(2) The weighted average exercise price does not reflect the shares that will be issued in connection with the settlement of RSUs and PSUs, since RSUs and PSUs have no exercise price.
(3)
Consists of shares available for future issuance under our 2022 Plan.
26
Table of Contents
Stock Performance Graph
The following graph compares the cumulative return to holders of our common stock for the five years ending March 31, 2025 with the NASDAQ Composite Total Returns Index and the Zacks Retail and Wholesale Auto Parts Index. The comparison assumes $100 was invested at the close of business on March 31, 2020 in our common stock and in each of the comparison groups, and assumes reinvestment of dividends.
27
Table of Contents
Item 6. Selected Financial Data
None.
28
Table of Contents